Santen Pharmaceutical Co., Ltd. logo

Santen Pharmaceutical Co., Ltd.

TSE:4536.T

Overview | Financials
Company Name Santen Pharmaceutical Co., Ltd.
Symbol 4536.T
Currency JPY
Price 1,749
Market Cap 622,035,234,315
Dividend Yield 2.05%
52-week-range 1,255 - 1,878.5
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Takeshi Ito
Website https://www.santen.com

An error occurred while fetching data.

About Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial;

Related Stocks

Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd.

4506.T

608 JPY

Taisho Pharmaceutical Holdings Co., Ltd. logo

Taisho Pharmaceutical Holdings Co., Ltd.

4581.T

8,580 JPY

COSMOS Pharmaceutical Corporation logo

COSMOS Pharmaceutical Corporation

3349.T

7,358 JPY

MediPal Holdings Corporation logo

MediPal Holdings Corporation

7459.T

2,554.5 JPY

Alfresa Holdings Corporation logo

Alfresa Holdings Corporation

2784.T

2,274 JPY

Tsuruha Holdings Inc. logo

Tsuruha Holdings Inc.

3391.T

8,613 JPY

Sugi Holdings Co.,Ltd. logo

Sugi Holdings Co.,Ltd.

7649.T

2,491 JPY

Sundrug Co.,Ltd. logo

Sundrug Co.,Ltd.

9989.T

4,083 JPY

Asahi Intecc Co., Ltd. logo

Asahi Intecc Co., Ltd.

7747.T

2,571 JPY

JCR Pharmaceuticals Co., Ltd. logo

JCR Pharmaceuticals Co., Ltd.

4552.T

654 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD